Status:
COMPLETED
Superior Vena Caval Obstruction (SVCO) - Management and Outcome
Lead Sponsor:
University Health Network, Toronto
Collaborating Sponsors:
Princess Margaret Hospital, Canada
Conditions:
Superior Vena Cava Syndrome
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
All patients with symptomatic malignant SVCO deemed suitable for treatment either with radiation therapy or by stenting will be eligible. They will receive whichever treatment is deemed most clinicall...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Symptomatic clinical and radiological diagnosis of superior vena caval obstruction.
- Underlying histological diagnosis deemed appropriate for palliative radiotherapy as treatment by investigator. Patients with chemosensitive tumours such as small cell lung cancer (both untreated and recurrent), lymphoma and testicular tumours, will be eligible if radiation is deemed to be appropriate treatment.
Exclusion
Key Trial Info
Start Date :
October 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2008
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00259584
Start Date
October 1 2001
End Date
October 1 2008
Last Update
August 13 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network
Toronto, Ontario, Canada, M5G 2M9